Nitric oxide (NO) is a signaling molecule involved in a wide spectrum of pathophysiological processes such as inflammation, apoptosis, regulation of enzyme activity, and gene expression. NO may modulate the cellular redox state by acting as an oxidant, thereby activating or inhibiting various enzymes involved in a number of signal transduction pathways. It is known that NO can regulate gene expression by modulating transcription factors, the translation or stability of mRNA (1) and the modification of proteins (2-4). It is also known that these effects of NO are differentially elicited by various concentrations of NO in the microenvironment. For instance, a low level of NO activates the cGMP second messenger system, namely the cGMP-dependent protein kinase pathway, in vascular smooth muscle and others (5-7). However, a high level of NO, such as that generated by inducible NO synthase or administered exogenously, will directly modify target proteins through S-nitrosylation of cysteine residues or nitration of tyrosine (Tyr) residues (2-4, 8, 9). We have previously identified a novel inhibitory role for NO in the transcription of the mouse kappa opioid receptor (KOR) gene in P19 embryonal carcinoma cells -a role mediated primarily through reduced expression of c-
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of the mouse gene can be initiated from two promoters, P1 and P2, separated by approximately 160 bp's. P2 is the major promoter where several transcription factors and regulatory DNA elements have been identified. For instance, three cis-acting elements for ME1a2, E2F and ME1a1 have been found in P2 (21, 22) . The pituitary tumortransforming gene (PTTG) product can bind to a region near the P2 initiation site as a protein complex containing the upstream stimulatory factor-1 (23) . A Smad-responsive element has been shown to be responsible for TGF-a mediated suppression of c-myc transcription (24) . An intron I X box is known to be involved in leukemia HL-60 differentiation (25, 26) . In addition, two functional NF-kB elements have been identified in both the human and the murine c-myc genes (27) (28) (29) , one located from -1261 to -1251 in the upstream region of P2 and the other located from +280 to +289. Importantly, transcription of the translocated c-myc gene in Burkitt's lymphoma is stimulated by constitutively expressed NF-kB (19). Our finding of rapid repression of c-Myc by NO in P19 cells (10) and the identification of two NF-kB binding sites in the c-myc promoter prompted us to examine the potential role of NF-kB in mediating NO regulation of c-myc in P19 cells.
NF-kB is an inducible transcription factor. Five members of NF-kB are known, including p50 (NF-kB1), p52 (NF-kB2), c-Rel, RelB and p65 (RelA). The major active form of this transcription factor is the p65/p50 heterodimer (30) (31) (32) . In most cells, NFkB complexes are predominantly cytoplasmic, and are usually associated with an inhibitory protein, the IkB family. Upon stimulation by pro-inflammatory cytokines such as tumor necrosis factor-a (TNF-a) or interleukin-1, NF-kB dimer dissociates from IkBa and is translocated into nuclei to act on the target gene (33, 34) . Translocation into nuclei is considered to be a general, underlying mechanism for the activation of NF-kB in gene regulation. It has been shown that NO can inhibit NF-kB by modifying the p50 subunit via redox-based S-nitrosylation of a cysteine residue in its N-terminal region. This effect of NO is sensitive to dithiothreitol (DTT) (4, 35, 36) . In our previous study, the effect of NO on c-Myc in P19 cells was not blocked by DTT (10), indicating the involvement of other NO-triggered mechanisms in the regulation of NF-kB activity. Chromatin Immunoprecipitation (ChIP) AssaysaeP19 cells were treated with SNP or SNP plus DFO for 6 h (or in a time-dependent manner), followed by cross-linking with 1% formaldehyde. ChIP assay was as described previously (10) by using 2 mg of antiAcH4, anti-p65, anti-p50, anti-HDAC1, or anti-HDAC2 antibodies. Precipitated DNA was amplified with primers specific to the URE flanking sequences in the endogenous cmyc promoter and to its 3' untranslated region (UTR), followed by Southern blot analyses of amplified endogenous c-myc sequences. to +289 relative to the promoter P2 (27, 28) , were found to be relevant ( Fig. 2A) . NF-kB has been shown to be a target protein of NO signal (3, 42) . We examined how the endogenous NF-kB activity in P19 cells might be affected by NO and augment c-myc gene expression. P19 cells were treated with SNP, followed by analyzing its nuclear extract for DNA binding ability to the kB binding sites of the c-myc promoter in EMSA. As shown antibody was able to supershift the minor species, the p50 complex (lane 6). The control, a non-specific antibody such as the anti-Sp1, had no effect (lane 7). Therefore, the URE consensus sequences of the c-myc gene indeed can be bound by p65/p50 heterodimer and p50 homodimer of NF-kB, but the major complex in P19 cells is the transcriptionally active p65/p50 heterodimer. The second putative NF-kB binding site, IRE, was also tested in EMSA as shown in (Fig. 2C ). The resistance of the same reporter activity to SNP in COS-1 cells was due to the absence of p65/p50 species binding to the URE in COS-1 cells that contained primarily the p50 species binding to the URE site (data not shown). To further confirm that the effect of SNP was indeed mediated by p65/p50 NF-kB, the specific reporter and a pMT2T-p65 expression vector (37) were simultaneously introduced into COS-1 cells (Fig. 3A) . Indeed, ectopic expression of p65 increased the specific reporter activity in COS-1 cells, which was again suppressed by SNP in a dose-dependent manner (Fig. 3B) . Thus, NO not only suppresses the DNA binding activity of p65/p50 NF-kB, but also efficiently reduces NF-kB activity in transcriptional control. The effect is primarily at the p65 subunit.
Repression of c-myc Gene Transcription by NO through PeroxynitriteaePreviously
we have suggested that S-nitrosylation was not involved in c-myc repression by SNP, a NO donor, in P19 cells because this suppressive effect could not be reversed by DTT, an agent that blocks S-nitrosylation of Cys residues by NO (10). Although it is accepted that NF-kB activity can be inhibited by NO through S-nitrosylation on a Cys residue of its p50 subunit (35, 36) 
Recruitment of HDACs 1 and 2 to the Endogenous c-myc Promoter by SNP
TreatmentaeThe activity of transcription factors can be modulated by altering the showed that in control cells, p65 and p50 were associated with the endogenous c-myc promoter regions flanking the URE site (top, left panel), but not the 3'-UTR (top, right panel). In SNP-treated cells, p65, but not p50 association was dramatically reduced. By using anti-HDAC1 and anti-HDAC2 antibodies in ChIP assays, it was apparent that both HDAC1 and HDAC2 were recruited to the endogenous c-myc promoter regions, but HDAC1 appeared to be preferentially recruited (bottom panels). Thus, SNP treatment triggers dissociation of p65, but not p50, from the endogenous c-myc promoter, correlated with increased HDACs recruitment to and decreased histone acetylation of this promoter.
To follow the dynamic behavior of transcription complexes on the endogenous c- , but a peroxynitrite scavenger, DFO, was able to do so (Fig. 4) . These results rule out S-nitrosylation as the underlying mechanism, and suggest that Tyr nitration could be the actual underlying mechanism for this novel effect of NO. It is proposed that an alternative pathway of protein modification by NO, possibly through Tyr nitration of the p65 subunit of NF-kB, is able to rapidly inactivate NF-kB activity.
We are in the process of determining specific Tyr residue(s) of NF-kB that could be NO targets.
NO is known to be involved in numerous pathophysiological processes. In particular, Tyr nitration of various proteins by peroxynitrite has been detected in a number of inflammatory or degenerative diseases (54, 55), and tumors (9, 56). As such, it has generated enthusiasm for managing diseases with agents that modulate NO signaling pathways. NF-kB is an important transcription factor that coordinates the expression of a wide variety of genes (57), and is known to be an inhibitor of apoptosis, because of its ability to induce anti-apoptotic factors such as cellular inhibitors of apoptosis (cIAPs) and the members of the BCL2 family (58, 59) . The c-Myc protein is involved in numerous important cellular processes, including proliferation, metabolism, cell cycle control, apoptosis, differentiation, genomic stability and tumor formation (11-13, 60, 61).
The ability of a NO donor, SNP, to directly and effectively repress NF-kB activity provides a potentially important route for therapeutic intervention of numerous disease conditions. In particular, its rapid transcriptional repression of c-myc gene via inactivating by guest on October 1, 2017
